Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF

Purpose. Truncated tissue factor (tTF) fusion protein targeting tumor vasculature can induce tumor vascular thrombosis and necrosis. Here, we generated (RGD)3-tTF in which three arginine-glycine-aspartic (RGD) targeting integrin αvβ3 and tTF induce blood coagulation in tumor vessels. Methods. The bi...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng-jie Huang, Yilin Zhao, Wei-yuan Luo, Jun You, Shui-wen Li, Wen-cheng Yi, Sheng-yu Wang, Jiang-hua Yan, Qi Luo
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/637086
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558834433916928
author Zheng-jie Huang
Yilin Zhao
Wei-yuan Luo
Jun You
Shui-wen Li
Wen-cheng Yi
Sheng-yu Wang
Jiang-hua Yan
Qi Luo
author_facet Zheng-jie Huang
Yilin Zhao
Wei-yuan Luo
Jun You
Shui-wen Li
Wen-cheng Yi
Sheng-yu Wang
Jiang-hua Yan
Qi Luo
author_sort Zheng-jie Huang
collection DOAJ
description Purpose. Truncated tissue factor (tTF) fusion protein targeting tumor vasculature can induce tumor vascular thrombosis and necrosis. Here, we generated (RGD)3-tTF in which three arginine-glycine-aspartic (RGD) targeting integrin αvβ3 and tTF induce blood coagulation in tumor vessels. Methods. The bioactivities of (RGD)3-tTF including coagulation activity, FX activation, and binding with integrin αvβ3 were performed. The fluorescent labeled (RGD)3-tTF was intravenously injected into tumor-bearing mice and traced in vivo. The tumor growth, volume, blood vessel thrombosis, tumor necrosis, and survival time of mice treated with (RGD)3-tTF were evaluated. Results. The clotting time and FX activation of (RGD)3-tTF were similar to that of TF (P>0.05) but different with that of RGD (P<0.05). (RGD)3-tTF presented a higher binding with αvβ3 than that of RGD and TF at the concentration of 0.2 μmol/L (P<0.05). (RGD)3-tTF could specifically assemble in tumor and be effective in reducing tumor growth by selectively inducing tumor blood vessels thrombosis and tumor necrosis which were absent in mice treated with RGD or TF. The survival time of mice treated with (RGD)3-tTF was higher than that of mice treated with TF or RGD (P<0.05). Conclusion. (RGD)3-tTF may be a promising strategy for the treatment of colorectal cancer.
format Article
id doaj-art-e7c4081e3eef4f43abc41eaf0a113a0b
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-e7c4081e3eef4f43abc41eaf0a113a0b2025-02-03T01:31:28ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/637086637086Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTFZheng-jie Huang0Yilin Zhao1Wei-yuan Luo2Jun You3Shui-wen Li4Wen-cheng Yi5Sheng-yu Wang6Jiang-hua Yan7Qi Luo8Department of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian Province 361004, ChinaDepartment of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaDepartment of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaDepartment of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaDepartment of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaCancer Research Center of Medical School, Xiamen University, Xiamen, Fujian Province 361102, ChinaCancer Research Center of Medical School, Xiamen University, Xiamen, Fujian Province 361102, ChinaDepartment of Surgical Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province 361003, ChinaPurpose. Truncated tissue factor (tTF) fusion protein targeting tumor vasculature can induce tumor vascular thrombosis and necrosis. Here, we generated (RGD)3-tTF in which three arginine-glycine-aspartic (RGD) targeting integrin αvβ3 and tTF induce blood coagulation in tumor vessels. Methods. The bioactivities of (RGD)3-tTF including coagulation activity, FX activation, and binding with integrin αvβ3 were performed. The fluorescent labeled (RGD)3-tTF was intravenously injected into tumor-bearing mice and traced in vivo. The tumor growth, volume, blood vessel thrombosis, tumor necrosis, and survival time of mice treated with (RGD)3-tTF were evaluated. Results. The clotting time and FX activation of (RGD)3-tTF were similar to that of TF (P>0.05) but different with that of RGD (P<0.05). (RGD)3-tTF presented a higher binding with αvβ3 than that of RGD and TF at the concentration of 0.2 μmol/L (P<0.05). (RGD)3-tTF could specifically assemble in tumor and be effective in reducing tumor growth by selectively inducing tumor blood vessels thrombosis and tumor necrosis which were absent in mice treated with RGD or TF. The survival time of mice treated with (RGD)3-tTF was higher than that of mice treated with TF or RGD (P<0.05). Conclusion. (RGD)3-tTF may be a promising strategy for the treatment of colorectal cancer.http://dx.doi.org/10.1155/2013/637086
spellingShingle Zheng-jie Huang
Yilin Zhao
Wei-yuan Luo
Jun You
Shui-wen Li
Wen-cheng Yi
Sheng-yu Wang
Jiang-hua Yan
Qi Luo
Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
The Scientific World Journal
title Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
title_full Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
title_fullStr Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
title_full_unstemmed Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
title_short Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)3-tTF
title_sort targeting the vasculature of colorectal carcinoma with a fused protein of rgd 3 ttf
url http://dx.doi.org/10.1155/2013/637086
work_keys_str_mv AT zhengjiehuang targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT yilinzhao targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT weiyuanluo targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT junyou targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT shuiwenli targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT wenchengyi targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT shengyuwang targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT jianghuayan targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf
AT qiluo targetingthevasculatureofcolorectalcarcinomawithafusedproteinofrgd3ttf